HDAC3-IN-6
HDAC3-IN-6 (Compound SC26) is a selective HDAC3 inhibitor with an IC50 of 53 nM. HDAC3-IN-6 dose-dependently induces the expression of PD-L1. HDAC3-IN-6 induces more pronounced Apoptosis and production of ROS. HDAC3-IN-6 exhibits high antitumor efficacy against colorectal cancer[1].
Product Specifications
CAS Number
[3070532-72-5]
UNSPSC
12352005
Target
Apoptosis; HDAC; PD-1/PD-L1; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(C1=CC=C(CNC(C2=CN=C(C3=CC=C4OC=CC4=C3)N2)=O)C=C1)NNCCC
Molecular Formula
C23H23N5O3
Molecular Weight
417.46
References & Citations
[1]Sun Z, et al. Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy. J Med Chem. 2025 Feb 13;68 (3) :3048-3064.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H4329 96 Tests
T-cell surface Glycoprotein CD3 epsilon chain (CD3E) Porcine ELISA Kit
Ask
View Details 
NBP3-20149C 0.1 mL
Rabbit Monoclonal TDRD3 Antibody (RAB-C419) [DyLight 650] - Chimeric
Ask
View Details